{
  "symbol": "FDMT",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology industry is prone to speculation",
      "Clinical-stage company with no commercial products",
      "Small market capitalization"
    ],
    "riskScore": 7,
    "reason": "4D Molecular Therapeutics operates in the speculative biotech sector with a small market cap and clinical-stage products, making it susceptible to retail-driven price movements."
  }
}